The Culture High- movie screening

The makers of the critically acclaimed "The Union", bring you the profound exploration of one of the most prolific wars of our time. "The Culture High" is the riveting story that tears into the very fiber of modern day marijuana prohibition to reveal the truth behind the arguments and motives governing both those who support and oppose the existing pot laws.

I'm excited to announce that "The Culture High" was accepted for screening in Georgia (Le Font Sandy Springs)! This movie is from the founder of the highly successful Netflix Documentary "The Union". I'm working to get the word out now about this screening - we need 97 more people to sign up for tickets in the next two weeks.

Monday, October 13 7:30PM - 9:30PM

at Lefont Sandy Springs
5920 Roswell Road, Suite C-103, Atlanta, GA, US, 30342 (map)
$12.00 General
TCH Screening GA link
Official Trailer
Password: tchtrailer1980

The Culture High website

Pharmaceutical Failures: Acomplia and ‘Spice’


Through failed attempts to manipulate cannabinoids or their partner receptor system in our body, pharmaceutical companies have learned some valuable lessons about the whole plant synergy of cannabis medicine. The complex chemistry of the cannabis plant is intimately connected to the complex processes and transformations that occur in our bodies’ endocannabinoid system (ECS), and it is through this complex relationship that comes the extensive list of medical treatments. Scientists have had to use the beer-goggles of prohibitive organizations such as N.I.D.A. to create drugs from the emerging knowledge of the ECS, and it’s gotten ugly.

The symbiotic relationship between our bodies and this plant presents a natural mystery that is confounding the methods of modern medicines makers. The intimacy of the ECS and our health should not be underestimated and, in some cases, tinkered with.Rimonabant was designed to block the CB1 receptor in an attempt to produce the “reverse munchies” effect. It was released in France as an appetite suppressant named Acomplia, only to be withdrawn from the market due to potentially serious side effects. It was rejected by the U.S. F.D.A. for causing anxiety, depression, and suicidal thoughts.

(Acomplia was rejected by the U.S. F.D.A. for causing anxiety, depression, and suicidal thoughts.)

(Acomplia was rejected by the U.S. F.D.A. for causing anxiety, depression, and suicidal thoughts.)


Although drug company proponents contest that isolated pharmaceuticals are safer than raw herbs, the prohibition on the plant has created it’s own problems. In the past few years there has been a genesis of designer cannabinoid drugs that have made it onto the shelves of head shops and gas stations around the world. These compounds were formulated by Dr. John W. Huffman (JWH) in order to conduct experiments on human subjects without the use of plant derived cannabinoids. The research was funded exclusively by the National Institute of Drug Abuse whose narrow focus on “research to prevent and treat drug abuse and addiction”1 (source) callously blocks research into whole plant medicine. Dr. Huffman reports that the chemical blueprints of his compounds were stolen and are now being reproduced around the world. JWH has stated publicly that these compounds are unsafe, and reports are emerging of users involved in accidents related to its impairment.

(Spice and K2 are synthetic compounds marketed as ‘legal weed’)

(Spice and K2 are synthetic compounds marketed as ‘legal weed’)

“Spice” smoking blends like K-2 are made into “incense” by spraying JWH compounds soaked in acetone (nail polish remover) onto dried herbs like damiana. At about $420 an ounce, these products are labelled “not for human consumption,” yet are marketed as “Legal Weed,” sometimes causing anxiety and dizziness while offering no medical value. These synthetic constructs continue to run amuck, as the specific profile of these duplicate cannabinoids are unclassified by the law. “Many of these cannabinoids have been developed specifically so they’re not analogues of the other ones [...] Theoretically there are thousands that could be developed.”2 (source)

In light of this, it seems like another backfire of prohibition that synthetic copies of individual compounds originally found in the cannabis plant are being widely distributed. Evidence continues to emerge in favour of whole plant medicine despite the narrowly focussed research approval standards of organizations like the N.I.D.A. that precipitated this legal loophole for opportunistic chemists.

While drug companies attempt to patent isolated compounds, patients are better off vaporizing whole plant cannabis for fast relief, eating medibles for a long sleep, or applying a massage oil to localize the effects. Cannabis dispensaries offer these options to patients at reduced cost, as they buy bulk ingredients and receive leaf donations from their caring growers.

Scientists have only been learning about cannabinoid receptors since 1988. The deeper they explore this complex system the more it reveals about cannabis and our health. As patients continue to inform doctors about how cannabis has helped them, scientists arduously attempt to target these previously untreatable conditions. However, today, it seems clear that the rigid approach afforded under prohibition can make a mess of even the purest intentions of science.

The few synthetic cannabinoid medicines we have available continue to fall short of the miraculous benefits attributed to whole plant products. The age old herb continues to help people heal in a myriad of ways, accumulating evidence that cannabis is indeed greater than the sum of its parts.


Marijuana Legalization Supported By A Growing Majority Of Americans, Survey Shows


A broad new survey shows that a majority of American adults continue to support marijuana legalization in the United States, and that support appears to be growing.

The survey, released last week from online polling data company CivicScience, asked more than 450,000 U.S. adults over the last two years this question: "Would you support or oppose a law in your state that would legalize, tax, and regulate marijuana like alcohol?"

Fifty-eight percent of respondents said they support marijuana legalization -- with 39 percent saying they "strongly support" and 19 percent saying they "somewhat support" reformed marijuana laws in their states. Thirty-five percent oppose legalization of marijuana -- with 29 percent "strongly" opposing and 6 percent "somewhat" opposing laws that would regulate marijuana like alcohol. Seven percent of respondents had no opinion on the issue.

CivicScience then broke out the data from just the last three months of responses -- from May to August -- and saw an increase in support and decrease in opposition to the regulation of marijuana like alcohol. Of those who responded most recently, 61 percent said they strongly or somewhat support marijuana legalization, while only 30 percent were opposed.

Finish Reading Here @ Huffpost

Kids Need THC, Too: Lawmakers Are Legalizing Certain Strains of Marijuana, but That Won't Be Good Enough


Republicans love marijuana. Pushed by a cadre of Christian brothers from Colorado and promoted by CNN's doctor-on-television Sanjay Gupta, a strain of marijuana acceptable for suburban squares and the churchgoing set is winning friends on the right. Marijuana low in THC but high in CBD — cannabidiol, one of the many compounds in cannabis — has real palliative value for people who medicine has failed. Specifically, it appears to treat kids with (previously) untreatable epilepsy. And best of all: It's impossible to get high off of.

That's ideal for conservative lawmakers. After several years of watching constituents flee their districts for the West and access to cannabis cures, they've taken action. Eleven states have now passed laws to legalize this stoner-unfriendly weed, while keeping THC-laden marijuana outlawed. A bill to do the same on the federal level was introduced in Congress in late July. The name of the Colorado brothers' strain of cannabis — Charlotte's Web, a proprietary trademark named for the first child to successfully treat her epilepsy with the product — is in the proposed law's title.

This same marijuana would not have saved Mykayla Comstock's life, her family says.

After six weeks of exhaustion, stomach pain, and labored breathing, the Oregon 7-year-old was diagnosed with leukemia in 2012. Doctors said chemotherapy would work well immediately. Instead, she got worse. With permission from the state and from her oncologist, Mykayla's father Brandon Krenzler starting giving his daughter cannabis oil.

This marijuana was the same kind that would make you popular at a party: It had plenty of THC. It made Mykayla "visibly stoned" while Krenzler worked out the right dose. It also saved her life, he says: Within a month, the lymphoblasts — the malignant cells — disappeared.

More than two years later, the cancer is still gone, and an arduous medical treatment that included regular spinal taps is almost over. Throughout it all, Mykayla received regular doses of cannabis containing THC, tonic that left her "laughing, smiling, and playing" while beating back cancer, her dad says.

"We don't believe Charlotte's Web would have had the same reaction," Krenzler tells SF Weekly, citing the studies that showed cancer cells were shrunk or killed when exposed to THC.


Medical Marijuana Update

by Phillip Smith, September 10, 2014

The Florida initiative is in a close fight, hearings are coming in Hawaii, draft regulations are coming in Maryland, Illinois begins taking medical marijuana business applications, and more. Let's get to it:



Last Thursday, a federal judge denied a request from Lake County patients for a temporary restraining order barring the county from carrying out searches and eradications under its Measure N grow rules. US District Judge Thelton Henderson ruled that the claims did not meet the legal standard required for a temporary restraining order, but held that plaintiffs could still seek a preliminary injunction.


Last Thursday, a new poll had the state medical marijuana initiative coming up just short. A new Florida Decides poll has a majority in favor of the Measure 2 medical marijuana initiative, but not the super-majority needed to pass a constitutional amendment. The poll had support at 57%, but 60% is needed. But the poll also had 17% undecided, and if only a fraction of the undecided break in favor of the initiative, it could win. Another poll earlier this week had support at 64%.


Last Friday, officials announced public hearings on dispensaries. A task force created by the state legislature to address dispensary issues will hold public hearings this week in Hilo and on September 24 in Honolulu. Click on the link for more details and information about how to submit public comments.


On Monday, the state began accepting applications for medical marijuana businesses. The state Agriculture Department is now taking applications from people who want to open dispensaries or cultivation centers. There are 22 licenses available for growers and 60 for dispensaries.


On Wednesdaythe state was waiting for new draft medical marijuana regulations. The Maryland Medical Marijuana Commission was expected to release a second draft of regulations for the state's medical marijuana program today. The first draft came under public criticism last month for, among other things, language that would have barred grows or dispensaries within the Baltimore city limits. That language has been removed. Stay tuned for the actual draft.

New Jersey

Last Fridaya Princeton employee was put on paid leave over his medical marijuana use. Princeton University campus dining manager Don DeZarn, who had been told to choose between his job and his medicine after he began legally using medical marijuana this summer, is now on paid leave as the school attempts to resolve the issue. The problem arose after DeZarn said he might use the drug while at work and school public safety officials raised concerns he could be impaired and might accidentally give a student with food allergies the wrong item (or something).

For extensive information about the medical marijuana debate, presented in a neutral format,]

Georgia Marijuana Advocates Seek Whole Plant Medicine: CBD Oil Only Legislation Unacceptable


ATLANTA, GA – As hearings continue in Macon on the limited medicinal use of the cannabis plant, advocates for medical marijuana question current the push for cannabidiol (CBD) oil – only legislation.

The advocacy group Georgia C.A.R.E. said whole plant therapeutics is the key to a success program that can potentially help many medical conditions not just a few children with epilepsy.

James Bell, director of Georgia C.A.R.E., said the state should be considering whole plant medicine that can help the most patients as soon as possible.

“The cannabis plant contains many compounds that have proven to be effective in treating a variety of conditions,” Bell said. “We should not be determining who can and cannot benefit from this healing plant.”

Bell said he is concerned that special interest lobbyists are attempting to influence the governor and the legislature to limit cannabis therapy to CBD extract only – a product drug companies hope to profit from.

Bell points out that whole-plant cannabis is legal in 23 states for such medical condition as cancer, glaucoma, PTSD, multiple sclerosis, Crohn’s disease, pain management, and more.

“Today the study committee will hear from adult patients with various medical conditions. We hope their testimony will convince lawmakers that we need to legalize the whole plant and allow doctors to treat patients who can benefit. Introducing a limited bill such as House Bill 885 will do little to get the medicine needed by so many,” Bell added.

Bell says he is also concerned that regardless of what type of legislation is introduced in 2015, some conservative lawmakers may attempt to kill the legislation as was done in 2014.

The N.F.L.’s Absurd Marijuana Policy


LOS ANGELES — VIRTUALLY every single player in the N.F.L. has a certifiable need for medical marijuana.

The game we celebrate creates a life of daily pain for those who play it. Some players choose marijuana to manage this pain, which allows them to perform at a high level without sacrificing their bodies or their minds.

I medicated with marijuana for most of my career as a tight end from 2003 through 2008. And I needed the medication. I broke my tibia, dislocated my shoulder, separated both shoulders, tore my groin off the bone once and my hamstring off the bone twice, broke fingers and ribs, tore my medial collateral ligament, suffered brain trauma, etc. Most players have similar medical charts. And every one of them needs the medicine.

Standard pain management in the N.F.L. is pain pills and pregame injections. But not all players favor the pill and needle approach. In my experience, many prefer marijuana. The attitude toward weed in the locker room mirrors the attitude in America at large. It’s not a big deal. Players have been familiar with it since adolescence, and those who use it do so to offset the brutality of the game. The fact that they made it to the N.F.L. at all means that their marijuana use is under control.

Had marijuana become a problem for me, it would have been reflected in my job performance, and I would have been cut. I took my job seriously and would not have allowed that to happen. The point is, marijuana and excellence on the playing field are not mutually exclusive.

A good example is Josh Gordon, the Cleveland Browns wide receiver who led the league last year with 1,646 receiving yards, despite missing two games for testing positive for codeine (for a strep throat, he said). He was suspended again late last month for the entire season after testing positive for marijuana. (At least five others were also suspended last year and this year for marijuana, according to the magazine Mother Jones.)


‘Lord, help me’: Might Macon woman be game-changer in medical marijuana debate?

BY JOE KOVAC JR.  September 6, 2014

Katie Crosby, 26, has been living with chronic pain of one form or another since her teen years. Today, the pain is so severe that she is mostly restricted to a pair of rooms in her childhood home. Crosby wants people like her who live in the middle ground between the terminally ill and those with rare seizures to be part of the argument for medical marijuana in Georgia. GRANT BLANKENSHIP — GPB

Katie Crosby, 26, has been living with chronic pain of one form or another since her teen years. Today, the pain is so severe that she is mostly restricted to a pair of rooms in her childhood home. Crosby wants people like her who live in the middle ground between the terminally ill and those with rare seizures to be part of the argument for medical marijuana in Georgia. GRANT BLANKENSHIP — GPB

It was early evening. The young woman’s living room was already dark. It almost always is. The blinds were shut, curtains drawn tight. Blankets hung over the curtains kept the faintest ray of late-day sun from piercing the blackness.

Still, there was light.

A 42-inch, flat-screen TV was on.

Katie Crosby’s beloved Georgia Bulldogs were playing Clemson in their football season opener.

She wasn’t about to miss that, even as the TV’s flicker triggered searing chronic pain that sometimes felt like it would split her in two.

Last weekend, despite wave upon crashing wave of migraine-grade misery, she sat still on her sofa, watching. The volume low, an ice pack on her head, a heating pad snug against her back.

In her upstairs apartment at her parents’ house in Macon, enduring what she described as “tremendous pain,” Crosby could hear the glee downstairs where friends and family were rooting on the Dawgs.

She used to holler at the TV when Georgia played. Sometimes she threw stuff. But no more. Sound or sudden movement can unleash agony.

Even as UGA running back Todd Gurley galloped for four touchdowns, Crosby didn’t flinch. She smiled. Nothing more.

It hurt too much to cheer.

Come Wednesday, the 25-year-old will leave her darkened home for the spotlight of a legislative panel at the center of Georgia’s medical marijuana debate, where she will try to open people’s eyes.

Finish Reading Here


Finally, Some Hard Science on Medical Marijuana for Epilepsy Patients

Matt Figi hugs his 7-year-old daughter Charlotte inside a Colorado greenhouse. The plants are a special strain of medical marijuana known as Charlotte's Web, which was named for Charlotte after she used the plant to treat epileptic seizuresBrennan Linsley—AP

Matt Figi hugs his 7-year-old daughter Charlotte inside a Colorado greenhouse. The plants are a special strain of medical marijuana known as Charlotte's Web, which was named for Charlotte after she used the plant to treat epileptic seizuresBrennan Linsley—AP

For years, some parents have turned to medical marijuana to treat their children’s debilitating epilepsy, crediting the drug with dramatically reducing seizure activity. A groundbreaking clinical trial about to begin recruiting test subjects may finally provide some science to back their claims.

In what is believed to be the first study of its kind, researchers at the University of Colorado, Denver will study the genes of those with a kind of epilepsy called Dravet Syndrome who have been treated with a strain of medical marijuana known as Charlotte’s Web. The study will attempt to determine if specific genetic components can explain why some epilepsy patients see positive results from ingesting Charlotte’s Web, while others do not.

The plant, grown by five brothers in Colorado through a non-profit organization called Realm of Caring, is low in THC, the compound that produces marijuana’s psychoactive effects, and high in CBD, a compound believed to reduce seizures in those suffering from certain forms of epilepsy. It is administered to epilepsy patients, including many children, in the form of an oil. The plant is named after Charlotte Figi, a young girl who was the first epilepsy patient successfully treated with the strain.

While anecdotal evidence suggests Charlotte’s Web can be highly effective in treating such conditions, scientific investigation of the product has been stymied by federal drug laws that severely limit marijuana research. Edward Maa, the principal investigator of the Charlotte’s Web study, says the new trial could be a first step toward building a body of research on how and why medical marijuana can be used to treat epilepsy. “This is the first attempt to get the information people are interested in that is observational in nature,” says Maa, an assistant professor at UC Denver and chief of the Comprehensive Epilepsy Programs at Denver Health.

The new study will recruit epilepsy patients who have already taken Charlotte’s Web. The patients will be divided into two groups—those who have seen seizure activity reduced by at least 50 percent on Charlotte’s Web and those who have had less dramatic or no results from taking the marijuana oil. Genetic analysis of the patients in both groups will then be performed in hopes of discovering what genetic components may cause a patient to be responsive to medical marijuana. Interventional studies, in which patients would be given Charlotte’s Web to measure its efficacy, are far more difficult to conduct. “That would be the Holy Grail,” says Maa.

Still, researchers on the UC Denver team will collect data on dosages used by patients in the study, for example, which could allow for further research down the line. “The more data we are able to collect in a large sample, the closer to the truth we will get,” says Maa. He says the study could allow children with Dravet Syndrome to be genetically screened before taking Charlotte’s Web so parents could know ahead of time if their children would benefit. It’s possible to conduct the study in Colorado because Charlotte’s Web is grown there legally and is home to many families who have moved to the state to specifically to access the marijuana strain.

“Do you uproot and move your entire family to not have an effect? I think this could be very helpful to answer this question,” says Maa.

Recruiting for the new study will begin within a month and data will be collected until February 2016.

Joint Committee Discussing Legalizing Marijuana in SC

Clark Fouraker, WLTX


The discussion comes after the General Assembly last session passed a bill legalizing industrial hemp, which also has THC, the substances that makes marijuana illegal.

"We see fit, that albeit a little bit different, should ride together," said Clint Leach with the South Carolina Department of Agriculture. "South Carolina is very unique in the agricultural history we have. It's different from other states so it's very important for us to look at the advantages and disadvantages that South Carolina brings to the table before we implement any law."

Lawmakers passed a bill legalizing industrial hemp last session and now have gathered a study committee to see if they should do the same with medical marijuana.

Industrial hemp is used by the textile industry to make products like clothing to soap.

Medical marijuana is different because it would be consumed by people.

"We have a role in the industrial hemp legislation and what we want to do with the other industries is figure out how we move this industry forward looking at what other states have done wether it be Colorado, or Kentucky, or Washington," Leach said.

Wednesday, lawmakers expect to hear about a law dealing with marijuana that's already on the books.

"The Marijuana and Controlled Substances Stamp Tax Act was passed in 1993," said Bonnie Swingle with the South Carolina Department of Revenue.

Without a legal marijuana industry, the tax hasn't earned the state very much. Since 1993, DOR has collected a little over $160,000 from the tax.

"(It) will help them determine wether they want to legalize it in the future, how much tax revenue they may get out of that," Swingle said.


Life sentence for buying marijuana?

By Vanita Gupta

Editor's note: CNN's David Mattingly reports on the case of a Missouri man sentenced to life in prison for purchasing marijuana Wednesday at 7 p.m. on Erin Burnett OutFront. Vanita Gupta is a deputy legal director at the American Civil Liberties Union and director of the organization's Center for Justice. The opinions expressed in this commentary are solely those of Vanita Gupta.

(CNN) -- Clearly something is broken when a Missouri man named Jeff Mizanskey can be sentenced to die in prison for purchasing seven pounds of marijuana. With two nonviolent marijuana convictions already on his record, Jeff received life without parole under Missouri's three strikes law.

The punishment of growing old and dying behind bars for offenses like Mizanskey's is extreme, tragic, and inhumane. This should outrage us, but it should not surprise us.

This country has spent 40 years relentlessly ratcheting up the number of people going to prison and dramatically expanding the time we hold them there. We've spent decades criminalizing people with drug dependency, passing extreme sentencing laws, and waging a war on drugs that has not diminished drug use. Small wonder, then, that even less serious crimes like Mizanskey's marijuana purchase result in costly and cruel sentences.

And Mizanskey is hardly the only one.

Just as he fell into the abyss of our nation's failed drug policies and excessive sentencing laws, millions more have sat in jails and prisons, often for years, even decades on end, for low-level drug and property offenses.

Click here for the rest of the story and video @ CNN

At 40, High Times branches out into partnerships and even a private equity fund


Go ahead, get the jokes out of your system. The staff of High Times, the counterculture drug magazine, has heard them all before.

For 40 years, they’ve put up with stoner quips and stereotypes. “People have this idea that we sit around and get high all day,” says Danny Danko, the magazine’s senior cultivation editor and author of its field guide to marijuana strains.

But as High Times celebrates its 40th anniversary with a special November issue that comes out Tuesday and is the largest in its history, the laughs are fewer and further between.

What started as an experiment by a mercurial provocateur and underground publisher has blossomed into an established brand, offering everything from licensing partnerships and an ever-expanding domestic events business to a just-launched private- equity fund. Along the way, something else changed: The magazine’s radical reason for being has stopped feeling so radical, even if the magazine itself hasn’t.

“There’s a feeling like now is our time in the sun,” said the editor in chief, Chris Simunek.


A Benefit of Legal Marijuana

Policy makers have suggested a variety of strategies to reduce injury and death from prescription opioid overdose, including drug-monitoring programs, scrutiny of doctors writing prescriptions and improved access to substance-abuse treatment.

Now a study has found evidence that legal access to marijuana is associated with fewer opioid overdose deaths. Researchers with the Department of Veterans Affairs found that in states where medical marijuana was legally available, death rates from opioid overdose were on average 24.8 percent lower than in states without medical marijuana.

The differences generally were even greater in states where medical marijuana had been available for longer periods. The study was published in JAMA Internal Medicine.
The authors acknowledge that various factors that are hard to measure may be at work, including differences among states in health behaviors, socioeconomic status, race, ethnicity, and medical or psychiatric diagnoses.

But by comparing the same state before and after the passage of medical marijuana laws, the researchers say they were able to control for population variations between states, even those they could not specifically identify.

They do not recommend the wide adoption of legalized cannabis on the basis of this study. Still, the lead author, Dr. Marcus A. Bachhuber, a fellow at the Philadelphia Veterans Affairs Medical Center, said that medical marijuana laws might have unexpected benefits.

“The next step would be a study of individuals over time,” he said. “If studies of individuals suggest that laws shift behavior, we could be reasonably confident of our results.”

What Marijuana Legalization Won't Be in 2016

Paul Waldman

Public opinion on the issue may look a lot like that on same-sex marriage, but the two differ in an important way.


If you're an advocate of marijuana legalization, you've had nothing but good news for some time now, and more keeps coming. Today at that snappy new Vox thing the hip kids put together, there's an article pointing out that although many people predicted a spike in crime once pot became legal in Colorado, statistics from Denver show that crime has actually declined a bit over the last few months compared to the same period in 2013. It's a small period of time, to be sure, but it doesn't look as though there has been an explosion of robberies or any other kind of crime.

And with the rapid movement of public opinion in favor of legalization, it would be easy to predict that politicians are going to be changing their positions very soon, or as the Atlantic puts it in an article today, "Weed Is the Sleeper Issue of 2016." OK, so we can put that headline down to an overzealous editor; the article itself, which runs through the positions of a number of potential presidential candidates, shows that none of them have actually changed their minds. (And a note of warning: if you see a reference to Rick Perry and "decriminalization," don't be confused. Though he has used the word himself out of what may be confusion, what he actually wants is for the cops to arrest you for possession and then send you to rehab instead of to jail. Which is better than going to jail, but not as good as just not being arrested in the first place.)

There's no question that the political profile of this issue is changing fast. But I doubt we're going to see much change from presidential candidates about it. This is where the analogy with same-sex marriage doesn't hold.

As we all know, public opinion on marriage equality shifted rapidly, and politicians shifted in response. In 2008, for instance, all the contending Democratic presidential candidate supported civil unions, but none supported full marriage rights. In the next presidential primary, all the Democrats will support marriage equality, and most if not all of the Republicans will probably be in favor of some form of civil unions.

Public opinion on marijuana legalization is very similar to that of marriage equality, both in the pattern of change and the correlation with age. Here are two graphs from the Pew Research Center that make it clear:


THC May Help Prevent the Growth of Alzheimer's Disease

By William Breathes in MedicalNews

A new study shows that low doses of THC can help reduce and even prohibit the growth of amyloid beta compounds in the brain - one of the key components to memory loss in Alzheimer's patients.


The study could represent a major breakthrough in the treatment of the disease, a horrible condition affecting more than 5 million people that robs them of their memories along with their ability to care for themselves. Alzheimer's disease affects the brain through the buildup of plaques through amino acids, known as amyloid betas. Pot, it seems, help stop that buildup.

"Decreased levels of amyloid beta means less aggregation, which may protect against the progression of Alzheimer's disease. Since THC is a natural and relatively safe amyloid inhibitor, THC or its analogs may help us develop an effective treatment in the future," neuroscientist Chuanhai Cao, a PhD at the Byrd Alzheimer's Institute at the University of South Florida College of Pharmacy, said in the study.

The study also showed that THC increases brain activity and transmission in key areas, including those associated with keeping the brain functioning properly. Researchers say they knew about THC's antioxidant properties before, but say that this is the first time that they've been able to show that THC was lowering the plaque-forming amino acids associated with Alzheimers while at the same time promoting increased brain activity.

Not only that, bud the researchers say that any adverse effects of cannabis use like memory loss or "toxicity" are far outweighed by the benefits of THC treatments for people with Alzheimer's. (Editor's note: What toxicity?)

But, of course, they are clinical doctors. So any THC used to treat this must be from a pharmacy, they say:

"Are we advocating that people use illicit drugs to prevent the disease? No. However, these findings may lead to the development of related compounds that are safe, legal, and useful in the treatment of Alzheimer's disease."

Israel’s Soldiers Can Smoke Medical Marijuana While in Service



Israel–yes, Israel–has long established itself as a leader on the forefront of medical marijuana. With a world-renowned, rock-solid medical program, an Israeli doctor’s discovery of CBD has long cemented the Middle Eastern nation as a hotbed for medical marijuana research.

But Israel–with over 11,000 registered medical marijuana patients–isn’t content with baseline progression. Last week, theIsraeli Defense Force announced that its military can legally smoke medical cannabis while on the job.

“The testing of the authorized officials indicate that a prescription for cannabis in itself has no effect on the medical profile.”

Translation: as long as an Israeli soldier has his or her medical marijuana card, he or she can medicate while serving active duty and while on Israel’s military bases–as long as he or she is in a secluded environment.

As LadyBud points out, no mainstream media outlet east of Israel has picked up on the story, so it’s unclear exactly how accurate this report may be. But if–as alleged–it’s from the horse’s mouth (Israel’s IDF), then it would appear to be a legitimate report.

And if so, it’s a major step for how countries could (and at least should) treat their soldiers’ cannabis use.

Numerous studies have shown that marijuana effectively treats PTSD and aids war-time stress. It’s immoral not to allow soldiers to use the medicine they’re legally provided, whether that army is Israeli or American or name that nation.

Hopefully, the ramifications from this bold, liberal mode carry over to other nations where medical marijuana is legal but smoking in service is certainly not.

Because no matter how you feel about Israel’s controversial foreign affairs, if you support marijuana reform, you can and should commend this effort to let soldiers medicate freely.

Meanwhile, in Uruguay, employees can legally go to work high.

This is the future, and in this future, smoking marijuana whenever, wherever is more likely than we could ever have imagined.